Safety and Immunogenicity Study of an Intranasal Shigella Flexneri 2a Invaplex 50 Vaccine.
Phase of Trial: Phase I
Latest Information Update: 05 May 2015
At a glance
- Drugs Shigella flexneri 2A vaccine (Primary)
- Indications Shigella infections
- Focus Adverse reactions; Pharmacodynamics
- 12 Jan 2010 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
- 12 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Nov 2006 Status change